로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > TRAIL R2

TRAIL R2

Brief Information

Name:Tumor necrosis factor receptor superfamily member 10B
Target Synonym:Tumor necrosis factor receptor superfamily member 10B,CD262,DR5,KILLER,TRAILR2,Death receptor 5,TRAIL-R2,UNQ160/PRO186,TNFRSF10B,TNF Receptor Superfamily Member 10b,TNF-Related Apoptosis-Inducing Ligand Receptor 2,TRICK2,ZTNFR9,P53-Regulated DNA Damage-Inducible Cell Death Receptor(Killer),Tumor Necrosis Factor Receptor-Like Protein ZTNFR9,Death Domain Containing Receptor For TRAIL/Apo-2L,Apoptosis Inducing Protein TRICK2A/2B,Apoptosis Inducing Receptor TRAIL-R2,Cytotoxic TRAIL Receptor-2,Fas-Li
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:11
Lastest Research Phase:Approved

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
TR2-C52H7 Cynomolgus Cynomolgus TRAIL R2 / DR5 / TNFRSF10B Protein, His Tag (MALS verified)
TR2-C52H7-structure
TR2-C52H7-sds
TR2-M52H5 Mouse Mouse TRAIL R2 / DR5 / TNFRSF10B Protein, His Tag
TR2-M52H5-structure
TR2-M52H5-sds
TR2-H82E6 Human Biotinylated Human TRAIL R2 / DR5 / TNFRSF10B Protein, Avitag™,His Tag (MALS verified)
TR2-H82E6-structure
TR2-H82E6-sds
TR2-H5255 Human Human TRAIL R2 / DR5 / TNFRSF10B Protein, Fc Tag
TR2-H5255-structure
TR2-H5255-sds
TR2-H5229 Human Human TRAIL R2 / DR5 / TNFRSF10B Protein, His Tag
TR2-H5229-structure
TR2-H5229-sds
ACRO Quality

Part of Bioactivity data

TR2-H5255-BLI
TRAIL R2 BLI

Loaded Human TRAIL R2, Fc Tag (Cat. No. TR2-H5255) on AHC Biosensor, can bind Human TRAIL, His Tag with an affinity constant of 0.146 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
TR2-M52H5-ELISA
TRAIL R2 ELISA

Immobilized Human TNFSF10 at 2 μg/mL (100 μL/well) can bind Mouse TRAIL R2, His Tag (Cat. No. TR2-M52H5) with a linear range of 0.039-0.625 μg/mL (QC tested).

Protocol

Synonym Name

TNFRSF10B,TRAILR2,TRAIL-R2,CD262,DR5,KILLER,TRICK2,ZTNFR9,TRICKB

Background

Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) is also known as TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2), Death receptor 5 (DR5), CD262, KILLER, is a member of the TNF-receptor superfamily, and contains an intracellular death domain.  TNFRSF10B / DR-5 is widely expressed in adult and fetal tissues; very highly expressed in tumor cell lines. TRAILR2 / CD262 / DR5 is the receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD (a death domain containing adaptor protein) of TRAIL-R2 / TNFRSF10B recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. CD262 / DR5 Promotes the activation of NF-kappa-B. DR5 is essential for ER stress-induced apoptosis and is regulated by p53/TP53.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Oba-01 Oba-01; Oba01 Phase 1 Clinical Yantai Heyuanaidisi Biomedical Technology Co Ltd Carcinoma, Non-Small-Cell Lung Details
Recombinant human tumor necrosis factor-related apoptosis-inducing ligand (Shenzhen Xinpeng Biotech) Phase 3 Clinical Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd Neoplasms Details
Recombinant anti-human DR5 monoclonal antibody (Lonn Ryonn Pharma) CTB-006 Phase 1 Clinical Beijing Tongwei Shidai Shengwu Jishu Youxian Gongsi Solid tumours Details
FAP-DR5 RG-7386; RO-6874813 Millennium Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd Details
Drozitumab R-7425; RG-7425; PRO-95780 Genentech Inc Details
Dulanermin (Shanghai GeBaiDe) Phase 3 Clinical Shanghai Gebaide Biotechnology Co Ltd Carcinoma, Non-Small-Cell Lung Details
Rilunermin alfa SCB-313 (TRAIL-Trimer) Phase 1 Clinical Sichuan Sanyecao Bio-Pharmaceutical Co Ltd Hydrothorax; Ascites; Peritoneal Neoplasms; Pleural Effusion, Malignant Details
DS-8273 DS-8273; DS-8273a Phase 1 Clinical Daiichi Sankyo Co Ltd Solid tumours; Colorectal Neoplasms; Lymphoma; Melanoma Details
Anti-DR5 CAR-T cell therapy (Shenzhen BinDeBio) Phase 2 Clinical Shenzhen Bindebio Ltd Esophageal Neoplasms; Stomach Neoplasms; Glioma; Carcinoma, Hepatocellular Details
INBRX-109 JCT-205; INBRX-109 Phase 1 Clinical Inhibrx Adenocarcinoma Details
IGM-8444 Phase 1 Clinical Igm Biosciences Inc Chondrosarcoma; Solid tumours; Sarcoma; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell Details
BI-905711 BI-905711 Phase 1 Clinical Boehringer Ingelheim Gmbh Pancreatic Neoplasms; Cholangiocarcinoma; Gastrointestinal Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
우리에게 전화하세요
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
Email
이메일
order.kr@acrobiosystems.com
Fax
팩스
+1 888-377-6111
Address
주소
서울 성동구 왕십리로10길 6 서울숲비즈포레 703
회사명
아크로바이오 주식회사
사업자 등록번호
186-88-02858
대표자
CHEN YIDING
사업장주소
서울특별시 송파구 중대로12길 10-20, 1층 셀렉티드송파(가락동)
linkedin twitter facebook youtube

문의

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap